A GLOBAL

LEADER IN DRUG

The pharmacology experimental platform allows KBP to identify and progress those
products with significant differentiation.

The platform is well integrated with KBP’s compound library and the bacteria collection.

KBP is dedicated to research and development of novel solutions of hypertension, cardiorenal, and infectious diseases around the world.

Benefiting from our proprietary R&D platform, we have established a strong pipeline of clinical and preclinical programs.

KBP is a world-class biotechnology research & development organization dedicated to providing innovative therapies for unmet medical needs.

Our integrated discovery and development platform enables us to efficiently bring new drugs from bench to clinics around the world.